SCHEMBL10114293

SCHEMBL10114293

CC(C)(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccccc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.62
NPY5R Q15761 1/20 0.58
GAA P10253 4/20 0.56
MAPT P10636 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
GFER P55789 1/20 0.56
HPGD P15428 2/20 0.54
RXRA P19793 1/20 0.51
RXRB P28702 1/20 0.51
RXRG P48443 1/20 0.51
FAAH O00519 1/20 0.50
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 1/20 0.49
NPC1 O15118 1/20 0.49
CASP3 P42574 1/20 0.49
RAB9A P51151 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
EPHX2 P34913 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10133376 1.00 GLA (0.62) GLANPY5RGAAMAPTMEN1
SCHEMBL13203733 0.95 MAPT (0.66) GLANPY5RGAAMAPTMEN1
SCHEMBL10113126 0.95 MAPT (0.66) GLANPY5RGAAMAPTMEN1
SCHEMBL10113217 0.92 NPY5R (0.54) GLANPY5RGAAMAPTMEN1
SCHEMBL10114466 0.92 NPY5R (0.54) GLANPY5RGAAMAPTMEN1
SCHEMBL13203763 0.92 NPY5R (0.54) GLANPY5RGAAMAPTMEN1
SCHEMBL14424747 0.92 NPY5R (0.54) GLANPY5RGAAMAPTMEN1
SCHEMBL10134412 0.91 GAA (0.54) GLANPY5RGAAMAPTMEN1
SCHEMBL10114390 0.91 GAA (0.54) GLANPY5RGAAMAPTMEN1
SCHEMBL10114400 0.89 NPY5R (0.56) GLANPY5RGAAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R GLA 1573/4885NPY5R 1/4885GAA 3448/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R GLA 1699/4885NPY5R 1/4885GAA 3316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.